- I think with the science advancing so nicely, immunotherapy is definitely a big thing we're seeing.

We're harnessing, or researchers have come up with really good medications where you harness the body's immune system to attack the cancer.

So that has really changed the landscape and the paradigm of the way to treat cancer, and also targeted treatments.

So you really, when the tumor is taken out, the pathologist and what we call next-gen sequencing, you can really tailor based on if there's a mutation found, then instead of just, like a buffet, just like giving any chemotherapy, we can actually tailor it to that mutation.

And so the child or the patient is getting more cancer-specific chemotherapy.

Those potentials and those options have advanced, and I think that's what makes it more promising for us.

It's like, okay, we have more options.

We can do something.

And so it's a very exciting time for oncologists because we feel like, okay, we can continue to do more.